Hello Alice Co-Founders Carolyn Rodz and Elizabeth Gore recently raised funds to continue to grow their company that supports startups and small businesses. Photos via helloalice.com

A tech company focused on supporting and growing startups and small businesses has reached its own next big growth milestone this week.

Machine learning-enabled small business support company Hello Alice, founded in Houston with a large presence in California, has closed its $21 million series B raise led by Virginia-based QED Investors with participation from new investors including Backstage Capital, Green Book Ventures, Harbert Growth Partners, and How Women Invest.

The raise comes at a pivotal time for the company, which worked hard during the pandemic to support struggling business and now aims to support entrepreneurs of all backgrounds as the world re-emerges out of the COVID-19 era. The fresh funds, according to a press release, will be used to refine the predictive capabilities on its platform, launch a mobile application, and more.

"These investments signal that despite the recent challenges small business owners have faced, there is an economic tidal wave that will revitalize Main Street, led by the entrepreneurs we serve," says Elizabeth Gore, co-founder and president of Hello Alice, in the release.

Since April 2020, Hello Alice has granted over $20 million in emergency funds and resources for small business owners affected by the pandemic. According to the release, the largest percentage of those grants went to "New Majority owners," especially people of color and women. Additionally, the company has reportedly experienced 1,100 percent growth and has expanded to support 500,000 small business owners weekly, with an increased revenue of more than 600 percent through its SaaS platform.

"We are thrilled to have a cap table as diverse as the business owners we serve," says Carolyn Rodz, co-founder and CEO of Hello Alice, in the release. "Our investors are leaders from the Black, Hispanic, LGBTQ+, Women, and US Veteran communities. As a Latina founder and fellow small business owner, I want to ensure that as our company grows, we are fueling future diversity in capital and breaking through ceilings for the benefit of our community."

According to a recent report Hello Alice produced in partnership with GGV Capital, now is the time to support small businesses. The report found that 83 percent of owners surveyed (which included 97,739 founders operating in all 50 states) believe their business will perform better in 2021 than in 2020. Most of the founders — 93 percent — plan to hire this year compared to the almost half — 45 percent — that laid off employees in 2020. Additionally, founders have an increased focus on tech — 75 percent said they are going to spend more on tech this year compared to last.

"Small business owners are the backbone of the U.S. economy, but many fail before they've had an opportunity to meaningfully serve the community in which they're based," says Frank Rotman, QED Investors Founding Partner, in the release. "Access to both capital and business expertise remain the biggest obstacles for SMBs, challenges heightened for women- and minority-owned businesses.

"Traditionally, corporations and government grants want to engage and support, but there hasn't been a source of truth on who can qualify for their diversity grants, funds and programs," he continues. "Hello Alice solves this problem, building tools that empower the new majority and enabling corporations and governments to support SMBs. Founders Carolyn and Elizabeth and the entire Hello Alice team are having a real, tangible impact on the ecosystem. We are incredibly excited to help them help others."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.